MENS Jyong Biotech Ltd. Ordinary Shares
Healthcare$2.15+3.37%ClosedMarket Cap: $163.5M
As of 2026-05-25
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
TW
Exchange
—
Beta
2.62
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
